Q517 - Pharmacy Medication Compounding Contingency Service

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

256-NETWORK CONTRACT OFFICE 16 (36C256)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25626Q0420

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

Q517

Additional Details
Set Aside

None

Place of Performance

Houston, TX

SourceSAM
Documents3
The Department of Veterans Affairs, through its 256-Network Contract Office 16, has issued a combined synopsis/solicitation for the provision of Pharmacy Medication Compounding Contingency Services at the Michael E. Debakey VA Medical Center in Houston, Texas. This procurement, identified by RFQ 36C25626Q0420, seeks to secure emergency contingency services for both hazardous and non-hazardous medication compounding, ensuring uninterrupted pharmaceutical support for the medical center’s operations. The scope of this requirement encompasses the compounding of medications under emergency or contingency circumstances, addressing both hazardous and non-hazardous pharmaceutical preparations. The intended outcome is to maintain continuity of care and medication availability for veterans served by the facility, particularly during periods when in-house compounding capabilities may be compromised or insufficient. Contractors are expected to provide commercial products and services in accordance with Federal Acquisition Regulation (FAR) subpart 12.202, utilizing streamlined procedures for evaluation and solicitation. Key requirements include the submission of pricing for specified medications as detailed in the Performance Work Statement (PWS), adherence to the delivery schedule outlined in section B.3, and compliance with all applicable FAR provisions and clauses. Offerors must affirm acceptance of the solicitation’s terms and conditions, or clearly state any exceptions with supporting rationale. Annual representations and certifications must be completed electronically via the System for Award Management (SAM) at https://sam.gov/. The place of performance and delivery is: Michael E. Debakey VA Medical Center Building 100, Room 2A-290 2002 Holcombe Blvd. Houston, TX 77030 United States This solicitation is unrestricted, allowing participation from all qualified entities regardless of business size. The associated North American Industrial Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing), with a small business size standard of 1,300 employees. The Product Service Code (PSC) is Q517, specifically relating to pharmacy compounding services. The procurement is managed by the 256-Network Contract Office 16, a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is Contract Specialist Eugene Jackson, who can be reached at [email protected] or 713-350-2938. All questions regarding the solicitation must be submitted via email by 3:00 PM CST on February 25, 2026. Quotes are due no later than 3:00 PM CST on March 4, 2026, and must be submitted electronically to the same contact. Contractors evaluating this opportunity should note the requirement for emergency and contingency compounding services, the need for timely and reliable delivery to the specified medical center location, and the expectation of compliance with federal acquisition regulations. The solicitation remains active, and all relevant documents and attachments can be accessed via the official SAM.gov opportunity page at https://sam.gov/opp/f3ef9b4c416b4378a6b96e106755c98f/view. This contract will require consistent performance in medication compounding and delivery, adherence to regulatory standards, and responsiveness to the needs of the VA medical center throughout its lifecycle.